| VEGF | Vascular endothelial growth factor |
| TSP | Thrombospondins |
| PGF | Placental growth factor |
| VEGFR | Vascular endothelial growth factor receptors |
| SCLC | Small cell lung cancer |
| NSCLC | Non-small cell lung cancer |
| TKI | Tyrosine kinase inhibitor |
| OS | Overall survival |
| PFS | Progression free survival |
| HIF-1 | Hypoxia-inducible factor |
| pCR | Pathologic complete response |
| DFS | Disease-free survival |
| PDGF | Platelet-derived growth factor receptor |
| FLT3 | Fms-related tyrosine kinase 3 |
| PD-L1 | Programmed death- ligand 1 |
| HDAC | Histone deacetylase |
| SAHA | Suberanilohydroxamic acid |
| TSA | Trichostatin A |
| NP1 | Neuropilin1 |
| NP2 | Neuropilin2 |
| miRs | MicroRNAs |
| EGCG | Epigallocatechin-3-O-gallate |
| PFKFB3 | Phosphofruktokinase-2/fructose-2,6-bisphosphatase 3 |
| MCT4 | Monocarboxylate transporter 4 |
| ATP | Adenosine triphosphate |
| MMP | Matrix metalloproteinase |
| TAM | Tumor-associated macrophages |
| TEM | TIE2 expressing macrophages |
| HSP | Heparin sulfate proteoglycan |
| bFGF | basic fibroblast growth factor |
| FGFR | Fibroblast growth factor receptor |
| IL-6 | Interleukin-6 |
| EC | Endothelial cells |
| VM | Vascular mimicry |
| VE-cadherin | Vascular endothelial cadherin |
| PECAM | Platelet EC adhesion molecule |
| PA | Plasminogen Activator |
| MCT4 | Monocarboxylate transporter 4 |
| EMT | Epithelial mesenchymal transition |
| EGFR | Epidermal growth factor receptor |